New 52 Week Low Today

Abcellera Biologics Inc ABCL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
30.27quote price arrow up+1.66 (+5.80%)
Volume
15,301
Close
28.61quote price arrow down-1.44 (-4.79%)
Volume
1,777,459
52 week range
26.16 - 71.91

...

Loading . . .

KEY STATS

  • Open30.51
  • Day High31.74
  • Day Low26.16
  • Prev Close30.05
  • 52 Week High71.91
  • 52 Week High Date12/11/20
  • 52 Week Low26.16
  • 52 Week Low Date03/05/21
  • Market Cap7.598B
  • Shares Out265.57M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.14
  • P/E (TTM)-199.37
  • Fwd P/E (NTM)8.40
  • EBITDA (MRQ)-11.559M
  • ROE (MRQ)-
  • Revenue (MRQ)20.45M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)1.36%
  • Debt To Equity (MRQ)2.53%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Abcellera Biologics Inc News

There is no recent news for this security.

Latest ABCL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
AbCellera Biologics Inc. is a biotechnology company, which offers drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. Its platform incorporates and integrates technology tools from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning and data science. The Company is engaged in the business of applying a multiple technology in its medical research and...
Carl Hansen Ph.D.
Chief Executive Officer
Andrew Booth
Chief Financial Officer
Tryn Stimart J.D.
General Counsel
Address
2215 Yukon Street
Vancouver, BC
V5Y 0A1
Canada